Nobel Prize Winner Views Medical Cannabis As 'A Real Therapeutic Treatment...Free Of Mysticism'


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


From the confines of a research lab to the mysterious realms of the cannabis world, Prof. Aaron Ciechanover's journey is nothing short of fascinating. This Nobel Prize winner in chemistry has, in recent years, chosen a path less traveled by his peers, immersing himself in the cannabis sphere with a desire, not to dwell on the mysticism of the plant, but to understand the intricate science behind it.

At 76, Prof. Ciechanover is not just a decorated chemist, renowned for his discovery of ubiquitin‐mediated protein degradation, but also a beacon in the biomedical community. But what compelled this Israeli biologist to dabble in cannabis?

‘A World Of Mystery’ Unveiled

In an exclusive interview, Ciechanover confessed his intrigue, "cannabis is a world of mystery." However, he was quick to clarify that his pivot wasn't born from the enigmatic allure of the plant. His passion lies in unraveling the mysteries through science and potentially offering therapeutic treatments rooted in medical cannabis. His knowledge, he hopes, along with other experts, will guide research and development in this burgeoning sector.

Shattering any semblance of the "Nobel aura," he candidly stated, "I don’t think the Nobel Prize adds anything to my scientific-medical abilities; it has no magic or superpowers." This humility, juxtaposed with his monumental achievement, further underscores his commitment to raw, unadulterated science.

While Prof. Ciechanover's foray into cannabis is recent, he's no stranger to the vast expanses of pharmaceutical sciences. His years as a practicing physician and consulting various pharmaceutical entities have enriched him with insights and experiences. These, he says, will be instrumental in navigating the multifaceted cannabis domain.

"This is the only way I know to be free of mysticism, and offer patients suffering from a wide range of medical conditions – some of which we have yet to discover – a real therapeutic treatment based on medical cannabis," Ciechanover passionately remarked.

In an industry on the cusp of exponential growth, Prof. Aaron Ciechanover stands as a testament to the harmonious blend of in-depth science and the promise of natural remedies. His journey from the world of chemistry to cannabis is emblematic of a broader shift, signifying the allure and potential of this ancient plant in modern medicine.

Image: AI


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechCannabisNewsMarketsInterviewGeneralAaron Ciechanover